Overview
Five-Year Financial Summary
Bayer Links
Investor Relations
Five-Year Financial Summary
| [Table 1.2] | |||||
|---|---|---|---|---|---|
| Bayer Group | 2005 | 2006 | 2007 | 2008 | 2009 |
| € million | € million | € million | € million | € million | |
| Sales | 24,701 | 28,956 | 32,385 | 32,918 | 31,168 |
| Sales outside Germany | 84.4% | 84.4% | 85.1% | 85.4% | 86.7% |
| EBIT* | 2,514 | 2,762 | 3,154 | 3,544 | 3,006 |
| EBIT before special items* | 3,047 | 3,479 | 4,287 | 4,342 | 3,772 |
| EBITDA* | 4,122 | 4,675 | 5,866 | 6,266 | 5,815 |
| EBITDA before special items* | 4,602 | 5,584 | 6,777 | 6,931 | 6,472 |
| Income before income taxes | 1,912 | 1,980 | 2,234 | 2,356 | 1,870 |
| Income after taxes | 1,595 | 1,695 | 4,716 | 1,724 | 1,359 |
| Noncurrent assets | 20,130 | 35,897 | 34,712 | 35,351 | 34,049 |
| of which goodwill and other intangible assets | 7,688 | 24,034 | 22,770 | 22,598 | 21,546 |
| of which property, plant and equipment | 8,321 | 8,867 | 8,819 | 9,492 | 9,409 |
| Current assets | 16,592 | 17,069 | 16,582 | 17,152 | 16,993 |
| Inventories | 5,504 | 6,153 | 6,217 | 6,681 | 6,091 |
| Receivables and other current assets | 7,798 | 8,001 | 7,834 | 8,377 | 8,177 |
| Cash and cash equivalents | 3,290 | 2,915 | 2,531 | 2,094 | 2,725 |
| Financial liablities | 8,952 | 19,801 | 14,417 | 16,870 | 12,949 |
| Noncurrent | 7,185 | 14,723 | 13,081 | 10,614 | 11,460 |
| Current | 1,767 | 5,078 | 1,336 | 6,256 | 1,489 |
| Interest expense – net | (338) | (728) | (701) | (702) | (548) |
| Return on equity | 14.4% | 14.1% | 31.8% | 10.4% | 7.7% |
| Gross cash flow** | 3,114 | 3,913 | 4,784 | 5,295 | 4,658 |
| Capital expenditures (total) | 1,400 | 1,939 | 1,905 | 1,982 | 1,669 |
| Depreciation and amortization | 1,758 | 2,086 | 2,478 | 2,570 | 2,660 |
| Personnel expenses (including pension expenses) | 5,318 | 6,630 | 7,571 | 7,491 | 7,776 |
| Number of employees*** (Dec. 31) | 82,600 | 106,000 | 106,200 | 108,600 | 108,400 |
| Research and development expenses | 1,729 | 2,297 | 2,578 | 2,653 | 2,746 |
| Equity including non-controlling interest (total) | 11,157 | 12,851 | 16,821 | 16,340 | 18,951 |
| Capital stock | 1,870 | 1,957 | 1,957 | 1,957 | 2,117 |
| Reserves | 9,287 | 10,894 | 14,864 | 14,383 | 16,834 |
| Net income | 1,597 | 1,683 | 4,711 | 1,719 | 1,359 |
| Non-controlling interest | 80 | 84 | 87 | 77 | 54 |
| Liabilities (total) | 25,565 | 43,040 | 34,557 | 36,171 | 32,091 |
| Total assets | 36,722 | 55,891 | 51,378 | 52,511 | 51,042 |
| Equity ratio | 30.4% | 23.0% | 32.7% | 31.1% | 37.1% |
| Bayer AG | |||||
| Net income | 613 | 1,250 | 1,928 | 1,161 | 2,226 |
| Allocation to (from) retained earnings | (81) | 486 | 896 | 91 | 1,068 |
| Total dividend payment | 694 | 764 | 1,032 | 1,070 | 1,158 |
| Dividend per share (€) | 0.95 | 1.00 | 1.35 | 1.40 | 1.40 |
figures for 2005-2008 as reported * for definition see “Calculation of EBIT(DA) Before Special Items” ** for definition see “Liquidity and Capital Expenditures of the Bayer Group” *** full-time equivalents | |||||
Advanced Search
